← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
American Life Science Pharmaceuticals
San Diego, CA
$7,127,382
Total funding
8
Grants
Funding over time
peak $1.4M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$7,127,382 · 8
By mechanism
R44$5,707,939 · 4
R21$638,543 · 2
R41$623,350 · 1
R43$157,550 · 1
Investigators at American Life Science Pharmaceuticals
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Gamma Secretase Assays to Discover Drugs for Alzheimer's$808,397
R44 · FY2006 · AG
Gamma Secretase Assays to Discover Drugs for Alzheimer's$763,308
R44 · FY2005 · AG
Development of protease inhibitor drugs to treat Alzheimer's disease$717,300
R44 · FY2010 · AG
Beta-Secretase Assays to Discover Drugs for Alzheimer's$598,044
R44 · FY2003 · AG
Development of E64d for Alzheimer's disease$581,324
R44 · FY2010 · AG
Development of E64d for Alzheimer's disease$567,196
R44 · FY2009 · AG
Cathepsin B inhibitor Drug Development for Traumatic Brain Injury$532,178
R41 · FY2018 · NS
Development of protease inhibitor drugs to treat Alzheimer's disease$427,472
R44 · FY2009 · AG
Beta-Secretase Assays to Discover Drugs for Alzheimer's$401,171
R44 · FY2002 · AG
Beta-Secretase Assays to Discover Drugs for Alzheimer's$378,993
R44 · FY2004 · AG
Prodrugs to treat Alzheimer's disease$215,306
R21 · FY2009 · AG
Development of protease inhibitor drugs to treat Alzheimer's disease$195,997
R44 · FY2009 · AG
Inhibitors of beta-Amyloid Production in Alzheimer's$163,200
R21 · FY2006 · AG
Inhibitors of beta-Amyloid Production in Alzheimer's$158,467
R21 · FY2007 · AG
Drugs to Elevate Enkephalin as Novel Opiate Analgesics$157,550
R43 · FY2004 · DA
Development of E64d for Alzheimer's disease$115,137
R44 · FY2008 · AG
Prodrugs to treat Alzheimer's disease$101,570
R21 · FY2010 · AG
Development of protease inhibitor drugs to treat Alzheimer's disease$95,089
R44 · FY2008 · AG
Development of E64d for Alzheimer's disease$58,511
R44 · FY2011 · AG
Development of a commercialization plan for traumatic brain injury therapeutics$55,000
R41 · FY2019 · NS